Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-15

Clinical Trial Update: A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating a probiotic-antibiotic combination to prevent recurrent urinary tract infections is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational probiotic-antibiotic combination for UTI prevention

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Recurrent Uti | EARLY_Phase 1 | Status: RECRUITING